Nootropil
Developed to target cortical functions and indicated to alleviate myoclonus symptoms.
Strengths: 400 · 800mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Myocalm
- Therapeutic class
Nootropic
- Pharmacological class
Pyrrolidone derivative
- Known off-label uses
cognitive impairment
- Contraindications
cerebral haemorrhage; severe renal impairment; huntington's chorea
- Precautions and warnings
monitor renal function; withdraw treatment gradually
- Minor side effects
nervousness; weight increase
- Moderate side effects
insomnia; agitation
- Serious side effects
haemorrhage — requires immediate medical attention
- Dosage forms
Film-coated tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
UCB Pharma
- Onset Time
1–2 weeks
- Duration
long-term
- Storage instructions
Store below 25°C.
- Drug interactions
thyroid hormones
- Age restrictions
Not recommended for children.
- Pregnancy and breastfeeding
Pregnancy: not recommended. Breastfeeding: not recommended.
Patient summary
Developed to target cortical functions and indicated to alleviate myoclonus symptoms.
Mechanism of action
Piracetam modulates neurotransmitter pathways and improves neuronal membrane fluidity, enhancing metabolic communication between cerebral hemispheres to support cognitive function.
Nootropil
Developed to target cortical functions and indicated to alleviate myoclonus symptoms.
Editorial Notes
- Active ingredient(s): Piracetam
- Listed indication(s): Myoclonus
Usually available as
- 180 tablets - 400 mg300-400-mg-14949
- 120 tablets - 800 mg300-800-mg-11641